GTBP vs SMCI · $17.4M cap vs P/E 26, rev $39.06B
GT Biopharma Inc (GTBP) versus Super Micro Computer Inc (SMCI) — a side-by-side from cached financials, not a winner call.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Super Micro Computer Inc (SMCI) is a computer hardware company listed on US. It is led by Charles Liang.
GTBP does not have a complete income-statement cache yet.
Latest reported SMCI revenue for 2026-06-30 was $39.06B. Net income was $2.23B. Revenue was up 77.8% from 2025-06-30 to 2026-06-30. SMCI currently screens at market cap $28.98B and trailing P/E 26.4.
GTBP currently screens at market cap $17.4M. SMCI currently screens at market cap $28.98B and trailing P/E 26.4.
Not investment advice. Open the GTBP and SMCI stock pages for the full models.
Not investment advice.